Cargando…

Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19

Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yingning, Wang, Zhen, Lian, Naqi, Wang, Yuzun, Zheng, Weiqiang, Xie, Keliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569706/
https://www.ncbi.nlm.nih.gov/pubmed/34746162
http://dx.doi.org/10.3389/fmed.2021.671215
_version_ 1784594693643829248
author Li, Yingning
Wang, Zhen
Lian, Naqi
Wang, Yuzun
Zheng, Weiqiang
Xie, Keliang
author_facet Li, Yingning
Wang, Zhen
Lian, Naqi
Wang, Yuzun
Zheng, Weiqiang
Xie, Keliang
author_sort Li, Yingning
collection PubMed
description Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19.
format Online
Article
Text
id pubmed-8569706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85697062021-11-06 Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19 Li, Yingning Wang, Zhen Lian, Naqi Wang, Yuzun Zheng, Weiqiang Xie, Keliang Front Med (Lausanne) Medicine Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment. The pathophysiological process of the COVID-19 is an excessive inflammatory response after an organism infects with a virus. Inflammatory storms play an important role in the development of the COVID-19. A large number of studies have confirmed that hydrogen has a therapeutic effect on many diseases via inhibiting excessive inflammatory cells and factors. Recently, a study led by the Academician Zhong Nanshan in China on the treatment of the patients with the COVID-19 by inhalation of a mixed gas composed of hydrogen and oxygen has attracted widespread international attention and hydrogen therapy has also been included in a new treatment plan for the COVID-19 in China. This study mainly describes the mechanism of occurrence of the COVID-19, summarizes the therapeutic effects and underlying mechanisms of hydrogen on the critical disease, and analyzes the feasibility and potential therapeutic targets of hydrogen for the treatment of the COVID-19. Frontiers Media S.A. 2021-10-22 /pmc/articles/PMC8569706/ /pubmed/34746162 http://dx.doi.org/10.3389/fmed.2021.671215 Text en Copyright © 2021 Li, Wang, Lian, Wang, Zheng and Xie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Li, Yingning
Wang, Zhen
Lian, Naqi
Wang, Yuzun
Zheng, Weiqiang
Xie, Keliang
Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
title Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
title_full Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
title_fullStr Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
title_full_unstemmed Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
title_short Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19
title_sort molecular hydrogen: a promising adjunctive strategy for the treatment of the covid-19
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569706/
https://www.ncbi.nlm.nih.gov/pubmed/34746162
http://dx.doi.org/10.3389/fmed.2021.671215
work_keys_str_mv AT liyingning molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19
AT wangzhen molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19
AT liannaqi molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19
AT wangyuzun molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19
AT zhengweiqiang molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19
AT xiekeliang molecularhydrogenapromisingadjunctivestrategyforthetreatmentofthecovid19